Baxter International (BAX) Stock Forecast, Price & News

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings or view top-rated stocks.

14 Wall Street analysts have issued 12-month price objectives for Baxter International's shares. Their BAX share price forecasts range from $43.00 to $62.00. On average, they predict the company's stock price to reach $51.07 in the next year. This suggests a possible upside of 36.8% from the stock's current price.
View analysts price targets for BAX or view top-rated stocks among Wall Street analysts.

Baxter International's stock was trading at $50.97 on January 1st, 2023. Since then, BAX shares have decreased by 26.8% and is now trading at $37.33.
View the best growth stocks for 2023 here.

Baxter International saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 7,170,000 shares, an increase of 10.8% from the August 15th total of 6,470,000 shares. Based on an average daily trading volume, of 4,580,000 shares, the short-interest ratio is currently 1.6 days. Currently, 1.4% of the company's shares are short sold.
View Baxter International's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our BAX earnings forecast.

Baxter International will be holding an earnings conference call on Thursday, November 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Baxter International Inc. (NYSE:BAX) posted its earnings results on Thursday, July, 27th. The medical instruments supplier reported $0.55 EPS for the quarter, missing analysts' consensus estimates of $0.59 by $0.04. The medical instruments supplier earned $3.71 billion during the quarter, compared to analyst estimates of $3.79 billion. Baxter International had a positive trailing twelve-month return on equity of 24.94% and a negative net margin of 19.00%.

Baxter International declared a quarterly dividend on Tuesday, July 18th. Stockholders of record on Friday, September 1st will be given a dividend of $0.29 per share on Monday, October 2nd. This represents a $1.16 dividend on an annualized basis and a dividend yield of 3.11%. The ex-dividend date is Thursday, August 31st.
Read our dividend analysis for BAX.

ETFs with the largest weight of Baxter International (NYSE:BAX) stock in their portfolio include Simplify Health Care ETF (PINK), BTD Capital Fund (DIP), First Trust Indxx Medical Devices ETF (MDEV), iShares U.S. Medical Devices ETF (IHI), BlackRock Large Cap Value ETF (BLCV), Invesco Zacks Mid-Cap ETF (CZA), Invesco S&P 500 Equal Weight Health Care ETF (RYH) and SPDR S&P Health Care Equipment ETF (XHE).

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 3.08%.
Read our dividend analysis for BAX.

Baxter International issued an update on its third quarter 2023 earnings guidance on Thursday, July, 27th. The company provided earnings per share (EPS) guidance of $0.65-$0.67 for the period, compared to the consensus EPS estimate of $0.80. The company issued revenue guidance of -.

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by many different retail and institutional investors. Top institutional investors include Geode Capital Management LLC (2.10%), Bank of New York Mellon Corp (0.76%), Cooke & Bieler LP (0.63%), California Public Employees Retirement System (0.62%), Coho Partners Ltd. (0.38%) and New York State Common Retirement Fund (0.29%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Jacqueline Kunzler and Jeanne K Mason.
View institutional ownership trends.

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BAX stock can currently be purchased for approximately $37.33.

Baxter International (NYSE:BAX) has a market capitalization of $18.90 billion and generates $15.18 billion in revenue each year. The medical instruments supplier earns $-2,433,000,000.00 in net income (profit) each year or ($5.66) on an earnings per share basis.

The company employs 60,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.